AstraZeneca PLC (AZN) 재무상태표
NYSE · Healthcare · Drug Manufacturers - General · 직원 96,100명 · CEO Pascal Claude Roland Soriot
- 주가
- $186.65 +7.02%
- 시가총액
- $2890억
- 기업가치
- $3160억
- 최근 실적
- Q3 '26 2026-10-30 제출
- 다음 실적
- 2027-02-09 EPS 추정 $2.41
AstraZeneca PLC (AZN)의 Q3 '26말 현금 및 단기투자는 $81.5억, 리스 포함 차입금은 $341억입니다. 자산총계 $1200억, 부채총계 $680억, 주주지분 $516억.
재무상태표
| 재무상태표 | 추세 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $58.4억 | $78.4억 | $69.2억 | $48억 | $54.9억 | $52.3억 | $70.6억 | $81.4억 | $57.1억 | $75.6억 | $48.9억 | $79.2억 | |
| 단기투자 | $2000만 | $1.8억 | $1.6억 | $1.33억 | $1.66억 | $1.65억 | $5000만 | $3900만 | $3000만 | $1.15억 | $7490만 | $2.3억 | |
| 매출채권 | $105억 | $111억 | $110억 | $119억 | $130억 | $133억 | $142억 | $143억 | $152억 | $141억 | $160억 | $164억 | |
| 재고자산 | $54.2억 | $53.4억 | $56.7억 | $56.6억 | $52.9억 | $58.8억 | $64.7억 | $65.9억 | $65.6억 | $65.7억 | $69.2억 | $68.7억 | |
| 기타 유동자산 | $16.4억 | $11.6억 | $16억 | $16.8억 | $19.1억 | $16.1억 | $12억 | $8.27억 | $12.5억 | $12.6억 | $7590만 | $2000만 | |
| 유동자산 | $251억 | $256억 | $254억 | $242억 | $258억 | $261억 | $289억 | $299억 | $287억 | $296억 | $279억 | $314억 | |
| 유형자산(순액) | $105억 | $106억 | $108억 | $115억 | $116억 | $123억 | $132억 | $138억 | $147억 | $149억 | $163억 | $167억 | |
| 장기투자 | $0 | $0 | $0 | $20.1억 | $17.3억 | $19억 | $48.5억 | $22.9억 | $25.3억 | $42.4억 | $46.6억 | $46.7억 | |
| 영업권 | $200억 | $200억 | $211억 | $211억 | $210억 | $211억 | $212억 | $212억 | $212억 | $212억 | $212억 | $211억 | |
| 무형자산 | $381억 | $388억 | $394억 | $394억 | $372억 | $376억 | $379억 | $382억 | $378억 | $369억 | $377억 | $381억 | |
| 이연법인세자산 | $47.2억 | $46.2억 | $47.3억 | $53.4억 | $53.5억 | $61억 | $62.6억 | $0 | $58.3억 | $55.9억 | $64.8억 | $66.4억 | |
| 기타 비유동자산 | $27.1억 | $26.5억 | $28.9억 | $13.7억 | $12.8억 | $11.4억 | $0 | $90.4억 | $32.1억 | $15.2억 | $15.1억 | $10.6억 | |
| 비유동자산 | $761억 | $767억 | $789억 | $808억 | $782억 | $801억 | $835억 | $845억 | $854억 | $844억 | $878억 | $883억 | |
| 자산총계 | $1010억 | $1020억 | $1040억 | $1050억 | $1040억 | $1060억 | $1120억 | $1140억 | $1140억 | $1140억 | $1160억 | $1200억 | |
| 부채 | |||||||||||||
| 매입채무 | $32.7억 | $197억 | $205억 | $217억 | $225억 | $225억 | $240억 | $250억 | $253억 | $225억 | $229억 | $235억 | |
| 단기차입금 | $51.3억 | $60.5억 | $50.7억 | $12.5억 | $21.6억 | $34.3억 | $64.9억 | $62억 | $31.9억 | $75.8억 | $62.3억 | $53.8억 | |
| 미지급세금 | $20.8억 | $16.3억 | $15.3억 | $14.7억 | $14.1억 | $0 | $14.3억 | $0 | $0 | $13억 | $0 | $0 | |
| 기타 유동부채 | $175억 | $12.4억 | $12.2억 | $12억 | $15억 | $28.1억 | $12.7억 | $11.8억 | $6.86억 | $8.07억 | $9.57억 | $6.79억 | |
| 유동부채 | $305억 | $289억 | $286억 | $259억 | $279억 | $291억 | $335억 | $341억 | $306억 | $326억 | $315억 | $312억 | |
| 장기차입금 | $224억 | $273억 | $272억 | $289억 | $265억 | $267억 | $247억 | $247억 | $247억 | $245억 | $237억 | $264억 | |
| 리스부채(비유동) | $8.57억 | $9.61억 | $9.49억 | $11.1억 | $11.1억 | $12억 | $12.7억 | $13.8억 | $14.2억 | $15.1억 | $23.2억 | $23.3억 | |
| 이연수익(비유동) | $700만 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연법인세부채 | $28.4억 | $26.2억 | $33.3억 | $35.7억 | $33.1억 | $0 | $36.2억 | $36억 | $35억 | $34.7억 | $34.6억 | $36.1억 | |
| 기타 비유동부채 | $53.4억 | $50.5억 | $46.7억 | $46.3억 | $43.7억 | $80.6억 | $44.8억 | $47.5억 | $51억 | $46.3억 | $44.4억 | $44.2억 | |
| 비유동부채 | $314억 | $359억 | $362억 | $382억 | $353억 | $360억 | $341억 | $344억 | $347억 | $341억 | $339억 | $368억 | |
| 부채총계 | $620억 | $648억 | $647억 | $641억 | $632억 | $651억 | $676억 | $685억 | $654억 | $666억 | $654억 | $680억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.88억 | $3.87억 | |
| 이익잉여금 | $15억 | -$2.12억 | $18.5억 | $31.4억 | $31.6억 | $33.6억 | $70.2억 | $82.1억 | $110억 | $96.7억 | $126억 | $140억 | |
| 기타포괄손익누계액 | $0 | $0 | $0 | $19.9억 | $0 | $20.5억 | $20.7억 | $20.4억 | $0 | $0 | $20.3억 | $19.8억 | |
| 주주지분 | $391억 | $374억 | $395억 | $407억 | $408억 | $410억 | $447억 | $459억 | $487억 | $473억 | $502억 | $516억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $286억 | $346억 | $335억 | $316억 | $301억 | $317억 | $328억 | $327억 | $297억 | $339억 | $322억 | $341억 | |
| 순차입금(차입금 - 현금) | $228억 | $267억 | $266억 | $268억 | $246억 | $265억 | $258억 | $245억 | $240억 | $264억 | $273억 | $262억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $50.2억 | $33.2억 | $48.3억 | $53.7억 | $78.3억 | $63.3억 | $61.7억 | $58.4억 | $54.9억 | $57.1억 | |
| 단기투자 | $8.84억 | $12.3억 | $8.49억 | $8.49억 | $1.6억 | $6900만 | $7700만 | $2000만 | $3700만 | $3000만 | |
| 매출채권 | $25.8억 | $28억 | $30억 | $49억 | $56.5억 | $81.3억 | $91.9억 | $84.1억 | $112억 | $152억 | |
| 재고자산 | $23.3억 | $30.4억 | $28.9억 | $31.9억 | $40.2억 | $89.8억 | $47억 | $54.2억 | $52.9억 | $65.6억 | |
| 기타 유동자산 | $23.1억 | $16.8억 | $30.8억 | $3.92억 | $1.42억 | $12.2억 | $11.3억 | $37.5억 | $20.4억 | $12.5억 | |
| 유동자산 | $133억 | $132억 | $156억 | $156억 | $195억 | $262억 | $226억 | $251억 | $258억 | $287억 | |
| 유형자산(순액) | $68.5억 | $76.2억 | $74.2억 | $83.4억 | $89.2억 | $102억 | $94.5억 | $105억 | $116억 | $147억 | |
| 장기투자 | -$5800만 | -$1.94억 | $1.13억 | $0 | $0 | $0 | $0 | $17.8억 | $0 | $25.3억 | |
| 영업권 | $117억 | $118억 | $117억 | $117억 | $118억 | $200억 | $198억 | $200억 | $210억 | $212억 | |
| 무형자산 | $276억 | $262억 | $220억 | $208억 | $209억 | $424억 | $393억 | $381억 | $372억 | $378억 | |
| 이연법인세자산 | $11억 | $21.9억 | $23.8억 | $27.2억 | $34.4억 | $43.3억 | $32.6억 | $0 | $53.5억 | $0 | |
| 기타 비유동자산 | $21.3억 | $25.8억 | $14.8억 | $22.6억 | $20.4억 | $22.3억 | $20.5억 | $56.5억 | $30.1억 | $90.4억 | |
| 비유동자산 | $493억 | $502억 | $451억 | $458억 | $472억 | $791억 | $739억 | $761억 | $782억 | $854억 | |
| 자산총계 | $625억 | $634억 | $607억 | $614억 | $667억 | $1050억 | $965억 | $1010억 | $1040억 | $1140억 | |
| 부채 | |||||||||||
| 매입채무 | $16.8억 | $22.9억 | $17.2억 | $17.7억 | $23.5억 | $28.2억 | $25.5억 | $32.7억 | $36.4억 | $253억 | |
| 미지급비용 | $72.5억 | $76.2억 | $90.7억 | $0 | $0 | $0 | $0 | $157억 | $0 | $0 | |
| 단기차입금 | $22.4억 | $22.7억 | $17.8억 | $18.2억 | $21.9억 | $15.7억 | $52.3억 | $51.3억 | $21.6억 | $31.9억 | |
| 미지급세금 | $13.8억 | $13.5억 | $11.6억 | $16.8억 | $15.2억 | $13.8억 | $13.6억 | $20.8억 | $18.1억 | $0 | |
| 이연수익 | -$58.8억 | -$64.4억 | $13.7억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 기타 유동부채 | $40억 | $42.1억 | $37.3억 | $99.6억 | $123억 | $149억 | $150억 | $61.3억 | $173억 | $6.86억 | |
| 유동부채 | $153억 | $164억 | $163억 | $181억 | $203억 | $226억 | $263억 | $305억 | $279억 | $306억 | |
| 장기차입금 | $165억 | $174억 | $192억 | $157억 | $175억 | $281억 | $230억 | $224억 | $265억 | $247억 | |
| 리스부채(비유동) | $600만 | $0 | $0 | $4.87억 | $4.89억 | $7.54억 | $7.25억 | $8.57억 | $11.1억 | $14.2억 | |
| 이연수익(비유동) | $0 | $0 | $7800만 | $5000만 | $3800만 | $2600만 | $1400만 | $700만 | $0 | $0 | |
| 이연법인세부채 | $39.6억 | $40억 | $32.9억 | $24.9억 | $29.2억 | $62.1억 | $29.4억 | $3100만 | $33.1억 | $35.1억 | |
| 기타 비유동부채 | $141억 | $129억 | $111억 | $99.1억 | $98.3억 | $83.6억 | $64.8억 | $81.5억 | $43.7억 | $51억 | |
| 비유동부채 | $306억 | $303억 | $303억 | $287억 | $308억 | $435억 | $331억 | $314억 | $353억 | $347억 | |
| 부채총계 | $459억 | $467억 | $466억 | $468억 | $511억 | $661억 | $594억 | $620억 | $632억 | $654억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $3.16억 | $3.17억 | $3.17억 | $3.28억 | $3.28억 | $3.87억 | $3.87억 | $3.88억 | $3.88억 | $3.88억 | |
| 이익잉여금 | $81.4억 | $82.2억 | $56.8억 | $28.1억 | $53억 | $17.1억 | -$5.74억 | $45.2억 | $31.6억 | $110억 | |
| 기타포괄손익누계액 | $9900만 | $10.1억 | $3400만 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 주주지분 | $149억 | $150억 | $125억 | $131억 | $156억 | $393억 | $370억 | $391억 | $408억 | $487억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $168억 | $178억 | $191억 | $182억 | $204억 | $307억 | $291억 | $286억 | $301억 | $297억 | |
| 순차입금(차입금 - 현금) | $118억 | $145억 | $143억 | $129억 | $125억 | $244억 | $230억 | $228억 | $246억 | $240억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep.
데이터 기준일 2026-11-01